Learn more

ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    19
  • GoodIP Patent Rank
    176,978
  • Filing trend
    ⇩ 100.0%
About

ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO LTD has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and environmental technology are TAICANG YUNTONG BIOCHEMICAL ENGINEERING CO LTD, ZHEJIANG GENEBEST PHARMACEUTICAL CO LTD and JIMING PHARMATECH SUZHOU LTD.

Patent filings in countries

World map showing ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO LTDs patent filings in countries

Patent filings per year

Chart showing ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhang Kehua 8
#2 Guo Zhenrong 8
#3 Feng Lichun 6
#4 Wang Zheqing 6
#5 Shu Lijian 5
#6 Ge Mengya 4
#7 Liu Sihong 3
#8 Sun Yunlei 3
#9 Chen Zhe 3
#10 Guo Weifeng 3

Latest patents

Publication Filing date Title
CN107501154A (S) synthetic method of the formonitrile HCN of 1 (2 chloracetyl) pyrrolidines 2
CN107245036A The method and apparatus of methylamine and the application in ephedrine and process of producing Pseudoephedrine are separated from the reaction waste containing methylamine
CN106008183A Preparation methods for ephedrine or pseudoephedrine and for ephedrine or pseudoephedrine intermediate
CN105541714A Preparation methods of papaverine and papaverine hydrochloride
CN104974106A Synthetic method of 5-alkyl-[1,3,4]-oxadiazole-2-formic acid alkyl ester
CN103739568A Preparation method of 2-(3-cyan-4-isobutoxyphenyl)-4-methylthiazole-5-formic acid A crystal
CN103709110A Preparation method of erlotinib hydrochloride key intermediate
CN103694171A Drotaverine hydrochloride crystal form III and crystal form IV and preparation method thereof
CN103664781A Drotaverine hydrochloride crystal form I and crystal form II and preparation method
CN104672141A Internal-(14S)-3-methoxy group-17-methyl morphinan picrate and preparation method and application thereof
CN103159759A Preparation method of moxifloxacin hydrochloride
CN103113333A Synthesizing method of vitamin C ethyl ether
CN103113290A Preparation method of Balofloxacin intermediate
CN103102341A Preparation method of balofloxacin dihydrate
CN102633659A Method for synthesizing trans-4-amino-1-hydroxy adamantane hydrochloride
CN102408427A Preparation method for moxifloxacin intermediate (1S, 6R)-8-benzyl-7, 9-dioxy-2, 8-diazabicyclo [4.3.0] nonane
CN102408313A Preparation method of R-3-butyne-2-alochol